Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Takhzyro loss of exclusivity?How do generic and branded tigecycline's side effects differ?Pembrolizumab 100 mg price?Patent litigation biotech today?Ezetimibe and statin?
See the DrugPatentWatch profile for Gadobutrol
Gadobutrol (brand names include Gadavist) is a gadolinium-based contrast agent used in MRI. It belongs to the class of extracellular, paramagnetic gadolinium contrast media used for diagnostic imaging, typically to help highlight abnormalities in the body on MRI scans. [1]
Gadobutrol is not a treatment for disease. It is administered to improve the visibility of tissues and lesions during MRI by altering local magnetic properties. Its classification is therefore centered on diagnostic contrast use rather than therapeutic drug effects. [1]
Gadobutrol is part of the broader group of gadolinium-based contrast agents (GBCAs). Within that group, it is used as an extracellular agent (it distributes primarily in the blood plasma and interstitial space rather than entering cells), which affects how clinicians interpret enhancement patterns on MRI. [1]
Because it is an MRI contrast agent, gadobutrol is used when clinicians need contrast-enhanced MRI to evaluate structures such as the brain, spine, or other body regions for suspected abnormalities. [1]
Other Questions About Gadobutrol :